Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for Gefitinib intermediates utilizing cheap raw materials, mild conditions, and avoiding toxic chlorinating agents for cost-effective production.
Patent CN107434756B reveals efficient iron-catalyzed coupling for non-terminal alkenes. Offers cost reduction and scalable manufacturing for high-purity pharmaceutical intermediates.
Advanced selenium-catalyzed method for monosulfide synthesis using CO and water. Offers high purity, atmospheric pressure operation, and significant cost reduction for pharmaceutical intermediates.
Advanced synthesis of P1,P4-di(uridine-5'-) tetraphosphate via metal-catalyzed coupling. Achieves high purity, low metal residue, and cost reduction in API manufacturing.
Patent CN103232467B reveals novel Sinomenine modifications offering superior anti-inflammatory activity and scalable synthesis for global pharmaceutical supply chains.
Novel 2-phenyl quinazoline derivatives targeting telomerase with high selectivity and low toxicity. Efficient synthesis routes for pharmaceutical intermediates.
Novel two-step synthesis from Michelactone offers high yield and scalability for Arglabin production reducing costs and ensuring supply chain reliability for oncology drug manufacturers
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.
Patent CN106905177A details high-yield synthesis for AHU-377 intermediate. Offers cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN117105967A reveals gold-catalyzed synthesis for high-purity organosilanes. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel one-pot method for pregnenolone derivatives using Oxone. Eliminates chromium waste, offers mild conditions, and ensures high-purity steroid intermediates for scalable API manufacturing.
Patent CN1182125C details a robust route for (2R,2-alpha-R,3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine, offering superior yield and purity for pharmaceutical supply chains.
Patent CN1487916A details an improved method for beta-3 agonist intermediates, offering higher yields and streamlined manufacturing for reliable pharmaceutical suppliers.
Novel five-step synthesis for Kv7.2 agonists delivers high purity and stable structure. Achieves over ninety-five percent yield for reliable pharmaceutical intermediate supply chains.
Patent CN106084015B reveals a breakthrough solid-phase method for carbetocin, achieving over 99.5% purity and significantly reducing impurities for reliable pharmaceutical intermediate sourcing.
Patent CN113979937A reveals a novel photocatalytic route for quinoline derivatives, eliminating strong oxidants to reduce equipment corrosion and lower manufacturing costs.
Patent CN102584800A details an asymmetric synthesis of chiral indolinone-angelica lactone frameworks using cinchona alkaloid catalysis, offering high enantioselectivity for pharmaceutical intermediates.
Patent CN113248356A reveals a scalable two-step route for 4-hydroxy-1-indanone, offering cost reduction in pharmaceutical intermediate manufacturing via mild acid catalysis.
Patent CN114751849A reveals a novel asymmetric Baeyer-Villiger oxidation route for brivaracetam intermediates, offering superior chiral purity and significant cost reduction in API manufacturing.
Novel ternary catalyst method for allyl glycidyl ether. High yield, no solid filtration, cost-effective supply for polymer and pharma industries.